{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:19:56Z","timestamp":1768825196476,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T00:00:00Z","timestamp":1332720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The relative merits of reduced\u2010intensity allogeneic stem cell transplantation (<jats:styled-content style=\"fixed-case\">RISCT<\/jats:styled-content>) for high\u2010risk indolent lymphoid malignancies are emerging, although the preferred conditioning regimen to manage the risks of graft\u2010versus\u2010host disease (<jats:styled-content style=\"fixed-case\">GVHD<\/jats:styled-content>) is not clearly defined. Here we report the outcome of 73 patients with lymphoid malignancies who received <jats:styled-content style=\"fixed-case\">RISCT<\/jats:styled-content> with a fludarabine\/cyclophosphosphamide conditioning regimen and a median follow\u2010up of 3\u00a0years. Median age was 54\u00a0years. Forty\u2010eight per cent of patients had previously undergone autologous stem cell transplantation with a median of three prior therapies. Non\u2010relapse mortality at 3\u00a0years was 19% but only 5% for patients with multiple myeloma (<jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>). Three\u2010year overall survival and current progression\u2010free survival was 67% and 63% respectively. Grade 2\u20134 acute <jats:styled-content style=\"fixed-case\">GVHD<\/jats:styled-content> occurred in 14% of patients while 49% had chronic <jats:styled-content style=\"fixed-case\">GVHD<\/jats:styled-content> requiring systemic immunosuppression. The preparatory regimen in this study has the advantage of reduced acute <jats:styled-content style=\"fixed-case\">GVHD<\/jats:styled-content> and low mortality, notably in patients with <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>. In addition, this strategy provides long\u2010term disease control in a significant proportion of patients with particular benefit in those with high\u2010risk follicular lymphoma.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09106.x","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T00:39:40Z","timestamp":1332808780000},"page":"580-585","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["<scp>T<\/scp>\u2010cell replete fludarabine\/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies"],"prefix":"10.1111","volume":"157","author":[{"given":"Rebecca L.","family":"Auer","sequence":"first","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Finlay","family":"MacDougall","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather E.","family":"Oakervee","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taussig","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff K.","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Syndercombe\u2010Court","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie D.","family":"Cavenagh","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Andrew","family":"Lister","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[{"name":"Department of Haemato\u2010Oncology St Bartholomew's Hospital  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,26]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.7279"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07905.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-238196"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404822"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.292"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404284"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.1"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07067.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-136242"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-211441"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1150"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.7929"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1105"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2003.50009"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017608"},{"key":"e_1_2_6_18_1","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07674.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.5477"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-438-4"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.057"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.3328"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.9100"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09106.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T12:16:29Z","timestamp":1700568989000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09106.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,26]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09106.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09106.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,26]]},"assertion":[{"value":"2011-07-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-01-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}